In the diabetes network, the unconditioned MASLD probability was 58%, with similar increases (~20%) observed after conditioning on high fasting insulin, BasalISR, or VAT, and low Clinsb, reinforcing the roles of hyperinsulinemia, insulin resistance, and visceral adiposity in hepatic steatosis. This evidence concerns the gene INS and fatty liver disease.